(Q37959290)

25 August 2017

title

Is there any value to hepatitis B virus genotype analysis? (English)

1 reference

25 August 2017

1 reference

1 reference

Sudeep Tanwar

1

1 reference

25 August 2017

Geoffrey Dusheiko

series ordinal

2

1 reference

25 August 2017

publication date

1 February 2012

1 reference

Current gastroenterology reports

25 August 2017

published in

1 reference

25 August 2017

volume

14

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

37-46

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-011-0233-5

25 August 2017

exact match

0 references

cites work

Global control of hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B: the virus and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

A "NEW" ANTIGEN IN LEUKEMIA SERA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

New Hepatitis B Surface Antigen Subtypes inside the ad Category

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

New complex recombinant genotype of hepatitis B virus identified in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Relationships between serotypes and genotypes of hepatitis B virus: genetic classification of HBV by use of surface genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotyping: current methods and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

T3098C and T53C mutations of HBV genotype C is associated with HBV infection progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Geographical and genetic diversity of the human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

High prevalence of hepatitis B virus genotype E in Northern Madagascar indicates a West-African lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus: the genotype E puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Natural history of chronic hepatitis B in Euro-Mediterranean and African countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B genotype C correlated with poor surgical outcomes for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

HBV genotype C is independently associated with cirrhosis in community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus: significance of genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Pegylated interferons for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Characterization of hepatitis virus B isolated from a multi-drug refractory patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0233-5

Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis

21 January 2018

1 reference

12 December 2020

Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity

1 reference

12 December 2020

Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA.

1 reference

12 December 2020

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

12 December 2020

Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region.

1 reference

12 December 2020

Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).

1 reference

12 December 2020

HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C.

1 reference

12 December 2020

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group

1 reference

12 December 2020

Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels

1 reference

12 December 2020

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescent

1 reference

12 December 2020

Identification of hepatitis B virus indigenous to chimpanzees

1 reference

12 December 2020

Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F

1 reference

12 December 2020

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

1 reference

12 December 2020

[Association between HBV genotype and chronic/severe liver disease with HBV infection in Chinese patients].

1 reference

12 December 2020

Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence

1 reference

12 December 2020

10.1007/S11894-011-0233-5

Identifiers

DOI

1 reference

25 August 2017

1 reference